T-cell response to myelin basic protein and lipid-bound myelin basic protein in patients with multiple sclerosis and healthy donors

Journal of Neuroimmunology

Volumn 82, Issue 1, 1998, Pages 96-100

  Mazzanti, Benedetta ^a,b   Vergelli, Marco ^a,b   Riccio, Paolo ^c,d   Martin, Roland ^a   McFarland, Henry F ^a   Liuzzi, Grazia M ^d   Amaducci, Luigi ^b   Massacesi, Luca ^b  

^a NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE   (United States)

^b UNIVERSITY OF FLORENCE   (Italy)

^c UNIVERSITY OF BASILICATA   (Italy)

^d CNR   (Italy)

Author keywords

Lipids; Multiple sclerosis; Myelin basic protein; T cells

Indexed keywords

MYELIN BASIC PROTEIN; PROTEOLIPID PROTEIN;

ARTICLE; AUTOIMMUNITY; HUMAN; HUMAN TISSUE; LYMPHOCYTE CULTURE; MULTIPLE SCLEROSIS; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN LIPID INTERACTION; T LYMPHOCYTE ACTIVATION;

CELL LINE; CROSS REACTIONS; HUMANS; LIPID METABOLISM; LIPIDS; MULTIPLE SCLEROSIS; MYELIN BASIC PROTEINS; T-LYMPHOCYTES;

EID: 0032005129     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-5728(97)00194-X     Document Type: Article

References (29)

1. Deibler G.E., Martenson R.E., Kies M.W. Large scale preparation of myelin basic protein from central nervous system tissue of several mammalian species. Prep. Biochem. 2:1972;139-165.
2. Deibler, G.E., Boyd, L.F., Kies, M.W., 1984. Proteolytic activity associated with purified myelin basic protein. In: Alvord, E.C., Jr., Kies, M.W., Suckling, A.J. (Eds.), Experimental Allergic Encephalomyelitis: A useful Model for Multiple Sclerosis. Alan R. Liss, New York, pp. 249-256.
3. Joshi N., Usuku K., Hauser S.L. The T-cell response to myelin basic protein in familial multiple sclerosis: Diversity of fine specificity, restricting elements and T-cell receptor usage. Ann. Neurol. 34:1993;385-393.
4. Kamholz J., Toffenetti J., Lazzarini R.A. Organization and expression of the human myelin basic protein gene. J. Neurosci. Res. 21:1988;62-70.
5. Knigge H., Simon M.M., Meuer S.C., Kramer M.D., Wallich R. The outer surface lipoprotein OspA of Borrelia burgdorferi provides co-stimulatory signals to normal human peripheral CD4+ and CD8+ T-lymphocytes. Eur. J. Immunol. 26:1996;2299-2303.
6. Liuzzi G.M., Tamborra R., Ventola A., Bisaccia F., Quagliarello E., Riccio P. Different recognition by clostripain of myelin basic protein in the lipid-free and the lipid-bound forms. Biochem. Biophys. Res. Commun. 226:1996;566-571.
7. Lolli F., Liuzzi G.M., Vergelli M., Massacesi L., Ballerini C., Amaducci L., Riccio P. Antibodies specific for the lipid-bound form of myelin basic protein during experimental autoimmune encephalomyelitis. J. Neuroimmunol. 44:1993;69-76.
8. Martin R., McFarland H.F., McFarlin D.E. Immunological aspects of demyelinating diseases. Annu. Rev. Immunol. 10:1992;153-187.
9. Martin R., Utz U., Coligan J.E., Richert J.R., Flerlage M., Robinson E., Stone R., Biddison W.E., McFarlin D.E., McFarland H.F. Diversity in fine specificity and T-cell receptor usage of the human CD4+ cytotoxic T-cell response specific for the immunodominant myelin basic protein peptide 87-106. J. Immunol. 148:1992;1359-1366.
10. Martin R., Voskuhl R., Flerlage M., McFarlin D.E., McFarland H.F. Myelin basic protein-specific T-cell responses in identical twins discordant or concordant for multiple sclerosis. Ann. Neurol. 34:1993;524-535.
11. Martin R., Whitaker J.N., Rhame L., Goodin R.R., McFarland H.F. Citrulline-containing myelin basic proteins recognized by T-cell lines derived from multiple sclerosis patients and healthy individuals. Neurology. 44:1994;123-129.
12. Martin R., McFarland H.F. Immunological aspects of experimental allergic encephalomyelitis and multiple sclerosis. Crit. Rev. Clin. Lab. Sci. 32:1995;121-182.
13. Massacesi L., Vergelli M., Zehetbauer B., Liuzzi G.M., Olivotto J., Ballerini C., Uccelli A., Mancardi L., Riccio P., Amaducci L. Induction of experimental autoimmune encephalomyelitis in rats and immune response to myelin basic protein in lipid-bound form. J. Neurol. Sci. 119:1993;91-98.
14. Moscarello, M.A., 1990. Myelin basic protein: A dynamically changing structure. In: Hashim, G.A., Moscarello, M. (Eds.), Dynamic Interactions of Myelin Proteins. Wiley, New York, pp. 25-48.
15. Mouritsen S., Medal M., Christiansen-Brams I., Elsner H., Werdelin O. Attachment of oligosaccharides to peptide antigen profoundly affects binding to major histocompatibility complex class II molecules and peptide immunogenicity. Eur. J. Immunol. 24:1994;1066-1072.
16. Norton, W.T., 1974. Isolation of myelin from nerve tissue. In: Fleischer, S., Packer, L. (Eds.), Methods in Enzymology. Academic Press, New York, pp. 435-444.
17. Olsson T., Sun J., Hillert J., Hojeberg B., Ekre H.P., Andersson G., Olerup O., Link H. Increased numbers of T-cells recognizing multiple myelin basic protein epitopes in multiple sclerosis. Eur. J. Immunol. 22:1992;1083-1087.
18. Ota K., Matsui M., Milford E.L., Mackin G.A., Weiner H.L., Hafler D.A. T-cell recognition of an immunodominant myelin basic protein epitope in multiple sclerosis. Nature. 346:1990;183-187.
19. Pette M., Fujita K., Kitze B., Whitaker J.N., Albert E., Kappos L., Wekerle H. Myelin basic protein-specific T-lymphocyte lines from MS patients and healthy individuals. Neurology. 40:1990;1770-1776.
20. Pette M., Fujita K., Wilkinson D., Altmann D.M., Trowsdale J., Giegerich G., Hinkkanen A., Epplen J.T., Kappos L., Wekerle H. Myelin autoreactivity in multiple sclerosis: Recognition of myelin basic protein in the context of HLA-DR2 products by T-lymphocytes of multiple sclerosis patients and healthy donors. Proc. Natl. Acad. Sci. USA. 87:1990;7968-7972.
21. Pinet V., Vergelli M., Martin R., Bakke O., Long E.O. Antigen presentation mediated by recycling of surface HLA-DR molecules. Nature. 375:1995;603-606.
22. Riccio P., Liuzzi G.M., Quagliarello E. Lipid-bound, native-like myelin basic protein: Batch-wise preparation and perspectives for use in demyelinating diseases. Mol. Chem. Neuropathol. 13:1990;185-194.
23. Riccio P., Bobba A., Romito E., Minetola M., Quagliarello E. A new detergent to purify CNS myelin basic protein isoforms in lipid-bound form. Neuroreport. 5:1994;689-692.
24. Simon M.M., Nerz G., Kramer M.D., Hurtenbach U., Schaible U.E., Wallich R. The outer surface lipoprotein A of borrelia burgdorferi provides direct and indirect augmenting/co-stimulatory signals for the activation of CD4+ and CD8+ T-cells. Immunol. Lett. 45:1995;137-142.
25. Vergelli M., Hemmer B., Utz U., Vogt A., Kalbus M., Tranquill L., Conlon P., Ling N., Steinmann L., McFarland H.F., Martin R. Differential activation of human autoreactive T-cell clones by altered peptide ligands derived from myelin basic protein peptide (87-99). Eur. J. Immunol. 26:1996;2624-2634.
26. Vergelli M., Pinet V., Vogt A.B., Kalbus M., Malnati M., Riccio P., Long E.O., Martin R. HLA-DR-restricted presentation of purified myelin basic protein is independent of intracellular processing. Eur. J. Immunol. 27:1997;941-951.
27. Voskuhl R.R., McFarlin D.E., Stone R., McFarland H.F. T-lymphocyte recognition of a portion of myelin basic protein encoded by an exon expressed during myelination. J. Neuroimmunol. 42:1993;187-192.
28. Wood D.D., Moscarello M.A. The isolation, characterization and lipid aggregating properties of citrulline containing myelin basic protein. J. Biol. Chem. 264:1989;5121-5127.
29. Zhang J., Markovic-Plese S., Lacet B., Raus J., Weiner H.L., Hafler D.A. Increased frequency of interleukin 2-responsive T-cells specific for myelin basic protein in peripheral blood and cerebrospinal fluid of patients with multiple sclerosis. J. Exp. Med. 179:1994;973-984.